Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 22 | 25 | 20 | 17 | 16 |
| Accounts receivable | 250 | -298 | 425 | -247 | -158 |
| Other Working Capital | 478 | -812 | 700 | 118 | -274 |
| Other Operating Activity | -1,176 | -736 | -1,396 | -278 | -1,060 |
| Operating Cash Flow | $-427 | $-1,822 | $-251 | $-391 | $-1,475 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -5 | 0 | 0 | -23 |
| Purchase Sale Intangibles | -3 | -15 | -15 | -28 | -41 |
| Other Investing Activity | 0 | -40 | 0 | 0 | 0 |
| Investing Cash Flow | $-25 | $-60 | $-15 | $-28 | $-63 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 49 | 1,628 | 307 | 233 | 227 |
| Debt Repayment | -138 | -11 | -8 | -1 | -1 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 695 |
| Other Financing Activity | 166 | 0 | 1,000 | 0 | 210 |
| Financing Cash Flow | $77 | $1,617 | $1,299 | $232 | $1,131 |
| Beginning Cash Position | 1,008 | 1,272 | 239 | 426 | 834 |
| End Cash Position | 633 | 1,008 | 1,272 | 239 | 426 |
| Net Cash Flow | $-375 | $-264 | $1,033 | $-187 | $-408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -427 | -1,822 | -251 | -391 | -1,475 |
| Capital Expenditure | -25 | -20 | -15 | -28 | -63 |
| Free Cash Flow | -452 | -1,841 | -266 | -419 | -1,539 |